International Journal of Toxicology (IJT) offers academic, industry, and regulatory toxicologists, as well as toxicology consultants, timely, peer-reviewed, multidisciplinary articles and incisive reviews on contemporary issues in toxicology, plus safety assessments, novel approaches to toxicological testing, mechanisms of toxicity, biomarkers, and risk assessment. Each issue of IJT provides an important forum for articles that promote basic toxicology research, as well as those that facilitate and improve toxicology practice.

IJT also publishes invited reviews, articles based on symposia, book and media reviews, and editorials. IJT publishes sponsored supplemental issues, including three issues each year devoted to contributions from the Cosmetic Ingredient Review Expert Panel.

Editor
Mary Beth Genter, PhD	University of Cincinnati, USA
Associate Editors
Bruce K. Bernard, PhD	SRA Consulting, Cambridge, MD, USA
Marion F. Ehrich, PhD	VA-MD Regional College of Veterinary Medicine, Blacksburg, VA, USA
Charles River	Ashland, OH
Donald G. Stump, PhD	 
Book Review Editor
Robert W. Kapp, Jr., PhD	BioTox, Monroe Township, NJ, USA
Editors Emeriti
M. Christian, PhD, Founding Editor	 
Robert M. Diener, DVM	 
Harihara M. Mehendale, PhD	 
Editorial Board
Krishna P. Allamneni, PhD	Jazz Pharmaceuticals Palo Alto, CA, USA
Shana Azri-Meehan, PhD	Johnson Matthey, Conshohonken, PA, USA
Theodore J. Baird, PhD	MPI Research, Mattawan, MI, USA
Sudheer R. Beedanagari, PhD	Alexion Pharmaceuticals, Boston, MA, USA
Lisa D. Beilke, PhD	Toxicology Solutions, Inc., San Diego, CA, USA
Susan Borghoff, PhD	ToxStrategies, Inc., Cary, NC, USA
William J Brock, PhD	Brock Scientific Consulting, Montgomery, MD
Alan P. Brown, PhD	Novartis Institutes for Biomedical Research, MA, USA
Lorrene A. Buckley, PhD	Eli Lilly and Company, Indianapolis, IN, USA
John A. Budny, PhD	PharmaCal, Westlake Village, CA, USA
Florence G. Burleson, PhD	BRT-Burleson Research Technologies, Inc., Morrisville, NC, USA
Gary R. Burleson, PhD	BRT-Burleson Research Technologies, Inc., Morrisville, NC, USA
Leigh Ann Burns Naas, PhD	Gilead Sciences, Inc., Foster City, CA, USA
Erica E. Carroll, DVM, PhD	Covance, Greenfield, IN
Charleata Carter, PhD	Carter Consulting, Greensboro, NC, USA
Scott Coleman, PhD	Spero Therapeutics, Attleboro, MA, USA
David Compton, PhD	Sanofi-Aventis, Bridgewater, NJ, USA
Matthew Z. Dieter, PhD	Eli Lilly and Company, Indianapolis, IN
Li-jie Fu, PhD	Shin Nippon Biomedical Labs, Ltd, Beijing, China
Shayne C. Gad, PhD	Gad Consulting Services, Cary, NC, USA
Hanan N. Ghantous, PhD	US FDA, Silver Spring, MD, USA
Robin C. Guy, MS	Robin Guy Consulting, LLC, Lake Forest, IL, USA
Bert Haenen, PhD	Janssen Research and Development, Beerse, Belgium
Jerry F. Hardisty	EPL Inc., Research Triangle Park, NC, USA
Stephen B. Harris, PhD	Stephen B. Harris Group, San Diego, CA, USA
Alan M. Hoberman, PhD	Charles River, Horsham, PA, USA
David W. Hobson, PhD	LoneStar PharmTox LLC, Boerne, TX, USA
Debie Hoivik, PhD	Boehringer Ingelheim Pharmaceuticals, Ridgefield, CT, USA
Heidi Hsieh, PhD	Covance, Madison, WI, USA
Elaine V. Knight, PhD	National Cancer Institute, Bethesda, Maryland, USA
Richard W. Lane, PhD	Lane Toxicology Consulting, LLC, Broomfield, CO
Palma Ann Marone	Virginia Commonwealth University, Virginia Beach, VA
Stephen B. Montgomery, PhD	Consulting Nonclinical Safety Assessment, Alpharetta, GA, USA
Barbara J. Mounho-Zamora, PhD	ToxStrategies, Inc., Bend, OR, USA
P. Balakrishna Murthy, PhD, DSc	Consultant Toxicologist, Chennai, India
Dennis J. Naas, BS, PMP	ProDev Consulting Services, Ltd., Traverse City, MI, USA
Kenneth J. Olivier, Jr., PhD	Morphic Therapeutics, Attleboro, MA, USA
Charles W. Qualls, Jr., DVM, PhD	Thousand Oaks, California, USA
Gunda Reddy, PhD	US Army CHPPM, Aberdeen Proving Ground, MD, USA
Mark Seaton, PhD	US FDA, Silver Spring, MD, USA
Viny Srinivasan, PhD, DABT, ERT	L'Oreal, Inc., USA
Alan H. Stokes, PhD	GSK, Rockville, MD, USA
Tao Wang, MD, PhD	Achaogen, San Francisco, USA
Adam Woolley, MSc, FRCPath	ForthTox Ltd., Linlithgow, Scotland, UK